India to Iraq: Valsartan Export Trade Route
India has recorded 186 verified shipments of Valsartan exported to Iraq, representing a combined trade value of $6.7M USD. This corridor is served by 11 active Indian exporters, with an average shipment value of $35.9K USD. The leading Indian exporter is AJANTA PHARMA LIMITED, which accounts for 75% of total export value with 124 shipments worth $5.0M USD. On the buying side, KAWKAB SCIENTIFIC BUREAU* is the largest importer in Iraq with $1.7M USD in purchases. The top 3 suppliers — AJANTA PHARMA LIMITED, AJANTA PHARMA LIMITED , SAM LIFESTYLE — together control 96% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Iraq Valsartan corridor is one of India's established pharmaceutical export routes, with 186 shipments documented worth a combined $6.7M USD. The route is dominated by AJANTA PHARMA LIMITED, which alone accounts for roughly 75% of all export value, reflecting the consolidated nature of India's valsartan manufacturing sector.
Across 11 active suppliers, the average shipment value stands at $35.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 90% of all shipments, consistent with valsartan's non-urgent bulk-order profile.
Shipment activity peaks during July-September, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 24.5%, placing it at rank #5 among India's top valsartan export destinations globally.
On the import side, key buyers of Indian valsartan in Iraq include KAWKAB SCIENTIFIC BUREAU*, AL-THURAYA SCIENTIFIC DRUG BUREAU, KAWKAB SCIENTIFIC BUREAU and 19 others. KAWKAB SCIENTIFIC BUREAU* is the single largest importer with 66 shipments valued at $1.7M USD.
